- AdventHealth
Surgeons at the AdventHealth Transplant Institute recently performed the 1,000th transplant in the program’s history.
The institute, Central Florida’s only solid organ transplant center, offers Floridians access to a top liver transplant center without leaving the state.
“We're able to handle one of the most difficult surgeries and continue to do so with excellent outcomes,” said Dr. Thomas Chin, the director of liver transplant who came to the institute in 2007 to start the liver transplant program. “I think that should bring a lot of confidence.”
The surgical team for the 1,000th procedure was led by Dr. Michael Angelis, assisted by surgeons, Dr. Phillip Wai and Chin.
“I think the fact that we’ve gotten here after just about 15-years is a tremendous accomplishment,” Chin said. “It’s very gratifying that we can really affect someone’s life in such a positive manner.”
Shelly Kalahar, the institute’s 716th liver transplant patient, said AdventHealth has, “The best people, the best doctors, the best surgeons, the best nurses. They’re the best people I’ve ever met in my life!”
Kalahar said her transplant has allowed her to spend five more Thanksgivings, and counting, with her family. She also pointed out how meaningful it is to belong to that exclusive group of AdventHealth Transplant Institute’s first 1,000 liver transplants.
“Oh, I think it’s awesome. It saved my life. A thousand people got to live longer,” Kalahar said.
Watch the video above to see Kalahari's inspiring and surprising personal transplant journey.
Many of the innovations and programs at the AdventHealth Transplant Institute are funded through philanthropy. Among them is the Bartch Transplant House — a home-away-from-home that provides housing, support, and amenities at an affordable cost for patients and families. Those amenities are funded through donations to the Patient Assistance Fund.
Recent News
AdventHealth Graduate Medical Education Program Celebrates 50 Years
Growing from a family practice residency to 24 accredited programs, AdventHealth’s Graduate Medical Education (GME) program celebrates 50 years.
AdventHealth Performs Central Florida’s First Liver Transplant for Unresectable Colorectal Liver Metastases
In June 2025, AdventHealth Abdominal Transplant Surgeon and Surgical Oncologist Ryan Day, MD, worked with a multidisciplinary team to perform Central Florida’s first liver transplant for unresectable...
AdventHealth Neuroscience Institute First in Florida to be Recognized as a GammaTile Center of Excellence
GammaTile is the first and only tile-based radiation therapy for the treatment of
operable brain tumors. The AdventHealth Neuroscience Institute began performing GammaTile procedures in 2021 and was...
An AdventHealth Collaboration Explores the Impact of Microgravity and Electrical Stimulation on Muscle Cell Health in Space
Using a muscle lab-on-chip model aboard the International Space Station (ISS), AdventHealth Translational Research Institute’s Dr. Paul Coen has been working with a multidisciplinary team from the...
AdventHealth Neuroscience Institute Administers First Dose of Investigative NK Cell Therapy to Person with Alzheimer’s Disease
Under a single compassionate use Investigational New Drug (IND) authorization cleared by the U.S. Food and Drug Administration (FDA), the AdventHealth Neuroscience Institute worked with NKGen Biotech...
New Study Published in the New England Journal of Medicine Shows the Addition of Regional Nodal Irradiation Does Not Decrease Rate of Invasive Breast Cancer Recurrence in Patients with Negative Axillary Nodes Following Neoadjuvant Chemotherapy
Findings of the phase III, multicenter, randomized NSABP B-51-RTOG 1304 clinical trial were recently published in the New England Journal of Medicine with AdventHealth Cancer Institute’s Dr. Mamounas...
AdventHealth Study Exploring the Use of MR-Guided Focused Ultrasound (MRgFUS) to Disrupt the Blood-Brain Barrier for Treatment of Alzheimer’s Disease
Under the leadership of Dr. Valeria Baldivieso and Dr. Chandan Reddy, the AdventHealth Research Institute is the first and only site in Orlando offering the Exablate Blood-Brain Barrier (BBB)...
AdventHealth Research Institute Offers Phase II Clinical Trial of Etanercept for Treatment of Blast-Induced Tinnitus
Approximately 1 billion people throughout the world suffer from tinnitus (ringing in the ears), and it is the number one disability of those who serve in the U.S. military. The condition can disrupt...
AdventHealth’s Karen D. Corbin, PhD, RD, Contributed to New American Diabetes Association Consensus Statement on Liver Disease in Diabetes
Metabolic dysfunction associated steatotic liver disease (MASLD), formerly referred to as nonalcoholic fatty liver disease (NAFLD), affects about 70% of people with type 2 diabetes, placing them at...
AdventHealth East Orlando First in Florida to Earn Advanced Foot & Ankle Surgery Certification from DNV
AdventHealth East Orlando recently became the first hospital in Florida to earn Advanced Foot & Ankle Surgery Certification from DNV, a worldwide, independent certification body.
Recent Study on How Physical Activity May Boost Neurocognition in Late Adulthood Featured in the Medical Journal Age and Ageing
In a new article published in the medical journal Age and Ageing, AdventHealth Research Institute’s Dr. Audrey Collins shares the results of a recent study evaluating the impact of exercise on...
AdventHealth Research Contributed to New Method for Tracking Diet and Its Impacts on Human Health
Accurately determining food intake remains a challenge in nutrition research. A new study published in Nature Metabolism and co-authored by Dr. Corbin introduces a metagenomics-powered approach to...